| 44567-237-06 |
44567-237 |
HUMAN PRESCRIPTION DRUG |
Ceftazidime |
Ceftazidime |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS |
20130131 |
N/A |
ANDA |
ANDA062640 |
WG Critical Care, LLC |
CEFTAZIDIME |
6 g/100mL |
6 VIAL in 1 CARTON (44567-237-06) / 100 mL in 1 VIAL |
| 44567-236-10 |
44567-236 |
HUMAN PRESCRIPTION DRUG |
Ceftazidime |
Ceftazidime |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS |
20130131 |
N/A |
ANDA |
ANDA062640 |
WG Critical Care, LLC |
CEFTAZIDIME |
2 g/1 |
10 VIAL in 1 CARTON (44567-236-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| 44567-235-25 |
44567-235 |
HUMAN PRESCRIPTION DRUG |
Ceftazidime |
Ceftazidime |
INJECTION, POWDER, FOR SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20130131 |
N/A |
ANDA |
ANDA062640 |
WG Critical Care, LLC |
CEFTAZIDIME |
1 g/1 |
25 VIAL in 1 CARTON (44567-235-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| 25021-128-50 |
25021-128 |
HUMAN PRESCRIPTION DRUG |
Ceftazidime |
ceftazidime |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS |
20080515 |
N/A |
ANDA |
ANDA062640 |
Sagent Pharmaceuticals |
CEFTAZIDIME |
2 g/1 |
10 VIAL in 1 CARTON (25021-128-50) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| 25021-127-20 |
25021-127 |
HUMAN PRESCRIPTION DRUG |
Ceftazidime |
ceftazidime |
INJECTION, POWDER, FOR SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20080515 |
N/A |
ANDA |
ANDA062640 |
Sagent Pharmaceuticals |
CEFTAZIDIME |
1 g/1 |
25 VIAL in 1 CARTON (25021-127-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| 25021-129-99 |
25021-129 |
HUMAN PRESCRIPTION DRUG |
Ceftazidime |
ceftazidime |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS |
20080515 |
N/A |
ANDA |
ANDA062640 |
Sagent Pharmaceuticals |
CEFTAZIDIME |
6 g/30mL |
6 BOTTLE in 1 CARTON (25021-129-99) / 30 mL in 1 BOTTLE |